Ticker Details
Janux Therapeutics, Inc.
IPO Date:	June 11, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$786.73M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.82 | 3.57%
Avg Daily Range (30 D):	$0.29 | 2.11%
Avg Daily Range (90 D):	$0.56 | 2.69%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	1.23M
Avg Daily Volume (90 D):	1.55M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	1,649
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$1.91M
Avg Institutional Trade (90 D):	$2.16M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.38M
Avg Closing Trade (30 D):	$2.41M
Avg Closing Trade (90 D):	$3.11M
Avg Closing Volume:	111.89K

News

Jan 22, 2026 @ 7:02 PM Janux Therapeutics Strikes Bristol Myers Biotech D... Source: Vandana Singh

Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman

May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.67	$-.39	$-.55
Diluted EPS	$-1.67	$-.39	$-.55
Revenue	$10M	$10M	$M
Gross Profit
Net Income / Loss	$-101.9M	$-24.31M	$-33.86M
Operating Income / Loss	$-144.29M	$-35.25M	$-45.12M
Cost of Revenue
Net Cash Flow	$21.64M	$-4.06M	$-21.3M
PE Ratio